The firm
Ten years spent turning conviction into care.
ICORP-Med was founded in 2015 by Stéphane Amine — founder of Inovalis and a pioneer of closed-end real estate placements in Europe — to bring that same institutional discipline to healthcare investing.
Our story
A team assembled around a single conviction.
Since inception, ICORP-Med has brought together healthcare professionals committed to transforming the system of care — making it more accessible, more performant, and more human.
We adopt a responsible, strategic investment approach that combines a long-term vision, rigorous management, deep expertise in risk analysis and a genuine sense of societal duty.
We select innovative projects with strong potential in critical sectors, with the objective of durable impact and a real benefit to the common good.
The ecosystem
Research and innovation at the heart of our DNA.
In front of today's health challenges — the digitisation of care and the integration of artificial intelligence — ICORP-Med concentrates on the research and development of advanced medical solutions to answer the most pressing questions in health.
Our collaborative approach optimises the efforts across our entities, accelerates innovation, and delivers greater benefit to patients by making solutions more accessible and effective.
01
Quality
We hold every process and every product to a clinical bar.
02
Integrity
Decisions grounded in evidence, honest with founders and LPs.
03
Durability
Built to last — companies, teams and patient outcomes.
04
Innovation
A restless curiosity for what science makes newly possible.
Founder
“We invest with the patience of an operator and the discipline of an institution. That is the only way to compound both returns and outcomes.”
Stéphane Amine · Founder, ICORP-Med
Leadership
The people behind ICORP-Med.
Stéphane Amine
Founder
Dani Abichala
Executive Director
Marc Amine
Executive Director